Table 1.

Studies investigating home blood pressure monitoring and prognosis

Study	Reference	Country	Population	N	Follow-up (years)	Outcomes
Ohasama	Ohkubo et al. [17]	Japan	General	1,789	6.6	All-cause mortality, CV mortality
Ohasama	Hozawa et al. [18]	Japan	General	1,913	8.6	CV mortality
Ohasama	Ohkubo et al. [20]	Japan	General	1,491	10.6	Stroke
Ohasama	Ohkubo et al. [21]	Japan	General	1,702	10.6	Stroke
Ohasama	Asayama et al. [22]	Japan	General	1,702	11.0	Stroke
Ohasama	Asayama et al. [23]	Japan	General	1,702	11.0	Stroke
Ohasama	Inoue et al. [24]	Japan	General	2,369	11.7	Stroke
PAMELA	Sega et al. [25]	Italy	General	2,051	10.9	All-cause mortality, CV mortality
PAMELA	Mancia et al. [26]	Italy	General	2,051	12.3	All-cause mortality, CV mortality
Didima	Stergiou et al. [27]	Greece	General	665	8.2	CV events
Finn-Home	Niiranen et al. [28••]	Finland	General	2,081	6.8	All-cause mortality, CV events
Flanders	Fagard et al. [29]	Belgium	Elderly	391	10.9	CV events
Nishinaga	Nishinaga et al. [30]	Japan	Elderly	461	9.0	Loss of functional independence
SHEAF	Bobrie et al. [31]	France	Elderly	4,939	3.2	All-cause mortality, CV mortality, CV events
Rave	Rave et al. [33]	Germany	Diabetic nephropathy	77	6.2	Decline in eGFR
Suzuki	Suzuki et al. [34]	Japan	CKD	113	3.0	Decline in eGFR
Agarwal	Agarwal and Andersen [35]	USA	CKD	217	3.5	All-cause mortality, ESRD
Agarwal	Agarwal and Andersen [37]	USA	CKD	217	3.4	All-cause mortality, CV events
Alborzi	Alborzi et al. [38]	USA	Hemodialysis	150	2.0	All-cause mortality, CV mortality
Agarwal	Agarwal [39••]	USA	Hemodialysis	326	2.4	All-cause mortality

CKD chronic kidney disease; CV cardiovascular; eGFR estimated glomerular filtration rate; ESRD, end-stage renal disease